4//SEC Filing
Smith Andrew Alasdair 4
Accession 0000950142-25-003241
CIK 0001997296other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:10 PM ET
Size
5.5 KB
Accession
0000950142-25-003241
Insider Transaction Report
Form 4
Smith Andrew Alasdair
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2025-12-16+50,000→ 50,000 totalExercise: $1.80Exp: 2030-12-16→ Common Shares (50,000 underlying)
Footnotes (1)
- [F1]The option was granted on December 16, 2025. The option is scheduled to vest quarterly in four equal installments over one year.
Documents
Issuer
Medicus Pharma Ltd.
CIK 0001997296
Entity typeother
Related Parties
1- filerCIK 0001309614
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 4:10 PM ET
- Size
- 5.5 KB